AFP Asia-Pacific welcomes Michael Mainville as its new regional director
Agence France-Presse (AFP) is pleased to announce that Michael Mainville has taken up his role as the new Asia-Pacific Regional Director as of April 3rd, 2023.
Moscow (AFP) | 05/09/2025 - 08:18:34 | Putin says any Western troops in Ukraine would be target for Russian army
San Francisco (AFP) | 05/09/2025 - 06:24:20 | US AI giant Anthropic bars Chinese-owned entities from services
Moscow (AFP) | 05/09/2025 - 05:02:43 | Kremlin says West 'cannot' provide Ukraine security guarantees: state media
Washington (AFP) | 05/09/2025 - 04:12:04 | Pentagon says Venezuelan planes buzzed US ship in 'highly provocative move'
Washington (AFP) | 05/09/2025 - 02:08:51 | Trump says will speak with Putin soon
Washington (AFP) | 05/09/2025 - 02:08:25 | Trump vows 'fairly substantial' chip tariffs soon
Washington (AFP) | 05/09/2025 - 01:53:59 | Trump rebrands Department of Defense as 'Department of War': White House
Washington (AFP) | 04/09/2025 - 23:23:51 | Trump signs order to lower US tariffs on Japan autos to 15%
New York (AFP) | 04/09/2025 - 21:09:10 | Boeing says it will hire replacements for striking US defense workers
Jerusalem (AFP) | 04/09/2025 - 20:08:28 | Israel condemns Gaza 'genocide' comments from EU official
Agence France-Presse (AFP) is pleased to announce that Michael Mainville has taken up his role as the new Asia-Pacific Regional Director as of April 3rd, 2023.
Debunking misinformation and publishing fact checks is essential but a new, unprecedented, project will soon help us understand better the disinformation phenomenon. “Narratives Observatory combatting Disinformation in Europe Systemically” or NODES is a pilot project set up by seven research and media partners including AFP, coming from four European countries and co-funded by the European Commission.
On August 6, 2025, VASTHERA Co., Ltd. announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VTB-10, its drug candidate for pulmonary arterial hypertension (PAH), a rare, life-threatening disease marked by elevated blood pressure in the lung arteries. VTB-10 is a first-in-class drug candidate developed using VASTHERA’s proprietary Redoxizyme™ platform. VASTHERA identified a deficiency of...
AFP has the largest network in the world of expert journalists in charge of digital investigations. AFP’s fact-check service is covering 36 countries. In Asia alone, 11 countries and territories in five languages, including English, Thai, Bahasa Indonesia, Bahasa Malay and Burmese. Burmese is the 14th language to be added to the AFP Fact Check website.